Literature DB >> 25145471

Neutrophils and oral squamous cell carcinoma: lessons learned and future directions.

Marco A O Magalhaes1, Judah E Glogauer2, Michael Glogauer2.   

Abstract

The role of cells of the innate immune system in the pathogenesis of squamous cell carcinoma has been the subject of intense research in recent years. In particular, neutrophils have been shown recently to have either a pro-tumor or anti-tumor phenotype in different cancers. Here, we review the role of neutrophils as tumor microenvironment and signaling modulators of OSCC and their possible role as biomarkers of OSCC prognosis. Current evidence supports a pro-tumor role for neutrophils in OSCC, but more research is needed to clarify the precise mechanisms involved.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  cancer immunology; inflammation; innate immunity; prognosis; tumor microenvironment

Mesh:

Substances:

Year:  2014        PMID: 25145471     DOI: 10.1189/jlb.4RU0614-294R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

1.  Melatonin represses oral squamous cell carcinoma metastasis by inhibiting tumor-associated neutrophils.

Authors:  Haibin Lu; Baolei Wu; Ge Ma; Deyu Zheng; Ruijuan Song; Erjiang Huang; Ming Mao; Bin Lu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.

Authors:  Martin Grimm; Johan Rieth; Sebastian Hoefert; Michael Krimmel; Sven Rieth; Peter Teriete; Susanne Kluba; Thorsten Biegner; Adelheid Munz; Siegmar Reinert
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-29       Impact factor: 2.503

3.  Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.

Authors:  Steve Oghumu; Thomas J Knobloch; Cesar Terrazas; Sanjay Varikuti; Jennifer Ahn-Jarvis; Claire E Bollinger; Hans Iwenofu; Christopher M Weghorst; Abhay R Satoskar
Journal:  Int J Cancer       Date:  2016-06-16       Impact factor: 7.396

4.  Prediction of lymph node metastasis in oral tongue squamous cell carcinoma using the neutrophil-to-lymphocyte ratio and platelet-to-neutrophil ratio.

Authors:  Bo Wang; Junwen Liu; Zhengrong Zhong
Journal:  J Clin Lab Anal       Date:  2021-05-04       Impact factor: 2.352

5.  Differential infiltration of neutrophils in T1-T2 versus T3-T4 oral squamous cell carcinomas: a preliminary study.

Authors:  Patrícia Carlos Caldeira; Alexandre de Andrade Sousa; Maria Cássia Ferreira de Aguiar
Journal:  BMC Res Notes       Date:  2015-10-14

6.  Interleukin-1 and estrogen protect against disseminating dentoalveolar infections.

Authors:  Hesham Youssef; Philip Stashenko
Journal:  Int J Oral Sci       Date:  2017-03       Impact factor: 6.344

Review 7.  Mediators of Inflammation - A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma.

Authors:  Mircea Tampa; Madalina Irina Mitran; Cristina Iulia Mitran; Maria Isabela Sarbu; Clara Matei; Ilinca Nicolae; Ana Caruntu; Sandra Milena Tocut; Mircea Ioan Popa; Constantin Caruntu; Simona Roxana Georgescu
Journal:  J Immunol Res       Date:  2018-11-12       Impact factor: 4.818

8.  Significant Neutrophilic Emperipolesis in Squamous Cell Carcinoma.

Authors:  Seza Tetikkurt; Faruk Taş; Funda Emre; Şule Özsoy; Zeki Tolga Bilece
Journal:  Case Rep Oncol Med       Date:  2018-11-13

Review 9.  Tumour-associated tissue eosinophilia (TATE) in oral squamous cell carcinoma: a comprehensive review.

Authors:  Marco Mascitti; Lucrezia Togni; Corrado Rubini; Giuseppe Troiano; Lorenzo Lo Muzio; Andrea Santarelli
Journal:  Histol Histopathol       Date:  2020-09-28       Impact factor: 2.303

10.  Role of Heterotypic Neutrophil-in-Tumor Structure in the Prognosis of Patients With Buccal Mucosa Squamous Cell Carcinoma.

Authors:  Jie Fan; Qigen Fang; Yang Yang; Meng Cui; Ming Zhao; Jinxing Qi; Ruihua Luo; Wei Du; Shanting Liu; Qiang Sun
Journal:  Front Oncol       Date:  2020-10-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.